Elon's $25 Trillion Confession

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
$36.81
Open 38.20 Prev Close 38.97
High 39.36 Low 36.57
Volume 1,877,816 Volume (Avg) 2,506
52 Week High 40.29 52 Week Low 9.57
Market Cap 5.1B PE Ratio

General

NameArrowhead Pharmaceuticals Inc
TickerARWR
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndSeptember
Full Time Employees609

About Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's product pipeline includes Plozasiran, which has completed Phase 3 clinical trial to treat hypertriglyceridemia, dyslipidemia, and familial chylomicronemia syndrome; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; and Fazirsiran that is in Phase 3 clinical trial for the treatment of liver disease associated with alpha-1 antitrypsin deficiency. It also develops Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; GSK-4532990 to treat metabolic-dysfunction associated steatohepatitis (MASH); and Daplusiran/Tomligisiran which is in Phase 2 clinical trial for the treatment of Chronic Hepatitis B. In addition, the company is developing ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with MASH; ARO-INHBE to reduce the hepatic expression of the INHBE gene and its secreted gene product; ARO-RAGE to treat inflammatory lung disease; ARO-MUC5AC to treat muco-obstructive pulmonary diseases; and ARO-MMP7 for the treatment of idiopathic pulmonary fibrosis that is in Phase 1/2a clinical trials. Further, it develops ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-DM1 to treat patient with Type 1 Myotonic Dystrophy; ARO-C3 to treat complement-mediated renal disease; ARO-CFB for the treatment of complement-mediated kidney disease that is in Phase 1/2a clinical trial; and ARO-ATXN2 for the treatment of Spinocerebellar Ataxia Type 2 that is in Phase 1 clinical trial. Arrowhead Pharmaceuticals, Inc. has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Horizon Therapeutics Ireland DAC; Takeda Pharmaceutical Company Limited; and with Amgen Inc. The company was founded in 2003 and is headquartered in Pasadena, California.

Highlights

Analyst Target43.00
Market Cap5,089,300,000
PEG Ratio-1.32
EBITDA-85,396,000

Valuation

Forward PE111.11
Price/Sales (Trailing 12 Mt.)9.40
Price/Book (Most Recent Quarter)9.16

Technicals

Beta1.23
52 Week High40.29
52 Week Low9.57
50 Day Average28.84%
200 Day Average89.71%

Earnings

Most Popular

Trump Commutes Former Rep. George Santos' Seven-Year Prison Term: '... Has Been Horribly Mistreated'

President Donald Trump announced on Friday that he commuted the prison sentence of former congressman George Santos (R-N.Y.), ordering his immediate release.

Steve Wozniak's Favorite Steve Jobs Movie Was A 1999 Release That Never Made It To The Cinemas: Here's Why He Loved Watching It

Apple Inc. (NASDAQ: AAPL) co-founder Steve Wozniak says Hollywood has captured Steve Jobs' best not in the splashy 2013 biopic starring Ashton Kutcher, "Jobs," but in a lower-profile 1999 made-for-TV film, "Pirates of Silicon Valley."

Oct 23: The Day Elon Changes Everything - Ad

Mark your calendar: October 23, 2025. That's the date I believe Elon Musk could finally unveil his Optimus robot - the same project he says will be "the biggest product ever of any kind." If Elon is right, this could be a $30 trillion tipping point...And regular investors have a rare window to move before the switch flips.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Cathie Wood, Tom Lee Align On These 10 Stock Picks: Some Might Surprise You

A new ETF from Tom Lee shares 10 stocks in common with Cathie Wood's Ark Funds. A look at the stocks both well-known financial figures like.

Louisiana judge orders review of Gulf Coast liquefied natural gas facility's climate change impacts

NEW ORLEANS (AP) — A Louisiana judge has tossed out a key permit for a liquefied natural gas facility that won approval from , ordering a state review of how the facility's planet-warming emissions would affect Gulf Coast communities vulnerable to sea-level rise and extreme weather.

This Company Could Challenge NVIDIA's Reign - Ad

This new chip can run at the speed of light and it's changing the game. "TF3" could replace silicon entirely and one American company is producing it commercially. Clients already include NASA and top medical research institutions. It's still under the radar - and that's the opportunity.

Macron is set to appoint a new French prime minister in last-ditch move to tackle turmoil

PARIS (AP) — After a week of intense political turmoil, French President is set to appoint a new prime minister Friday in his latest bid to break the political deadlock that has gripped the country for more than a year, as France struggles with mounting economic challenges and ballooning debt.

Analyst See Noise In Q3 P&L, Affirms Abbott's Medtech Strength

Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global expansion.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

Pam Bondi Says Meta Removed Facebook Page Used To 'Dox And Target' ICE Agents: 'Wave Of Violence' Against ICE Driven By Online Apps

Meta removed a Facebook page accused by the Justice Department of being used to "dox and target" ICE agents in Chicago, following similar actions by Apple and Google amid rising controversy over President Donald Trump's immigration enforcement tactics.

Giorgio Armani group names luxury veteran and longtime manager Giuseppe Marsocci as new CEO

ROME (AP) — The Armani fashion house said on Thursday it has appointed luxury veteran and longtime manager Giuseppe Marsocci as its new chief executive officer, following the

November 18: D-Day For The Dollar - Ad

A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on November 18. Investors who make the right moves before then could make up to 40X by 2032...

New York Times, AP, Newsmax among news outlets who say they won't sign new Pentagon rules

News organizations including The New York Times, The Associated Press and the conservative Newsmax television network said Monday they will not sign a Defense Department document about its new press rules, making it likely the Trump administration will evict their reporters from the Pentagon.

Ethereum Crashes To $4,100 As Senate Democrats Take Aim At DeFi

Ethereum (CRYPTO: ETH) is trading near $4,100 on Friday, after a sharp selloff that followed its rejection from $4,700 and renewed fears of U.S.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Demand For Electric Pickup Trucks Soar In Q3, Except If You're Tesla

New data shows the top-selling EV brands and companies for the U.S. in the third quarter. Strong demand for electric pickup trucks benefits several companies.

USA Rare Earth (USAR) Stock Is Rising Today: Here's Why

Shares of USA Rare Earth, Inc. (NASDAQ: USAR) are trading higher Monday amid a wave of optimism for rare earth materials companies.

On October 16, a powerful new law signed by President Trump will trigger a radical shift in America's money system... - Ad

When a small group of private companies - not the Fed - will perform a major mint of a new kind of money. And those who act before this new system fully kicks in could see gains as high as 40X by 2032. But those who fail to prepare will be blindsided by this sea change to the U.S. dollar.

Platinum's Incredible Rally Surprises Even The Insiders

Platinum has surged above $1,650/oz, making it 2025's best-performing precious metal. Demand in China and supply constraints are driving the rally.

Magnolia Oil & Gas Gets Upgrade On Strong Finances, Brighter Oil Outlook

KeyBanc raised Magnolia Oil & Gas to Overweight with a $29 target, citing a defensive profile and disciplined growth outlook.

This Makes NVIDIA Nervous - Ad

NVIDIA's AI chips use huge amounts of power. But a new chip could cut energy use by 99% and run 10 million times more efficiently. One U.S. company has cornered this market. They control the first commercial foundry in America. At under $20 a share, it's a ground-floor shot at the next tech giant.

Trump approves Alaska mining road to boost copper, zinc production

WASHINGTON (AP) — President Donald Trump on Monday ordered approval of a proposed 211-mile road through an Alaska wilderness to allow mining of copper, cobalt, gold and other minerals.

Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

Why Is BTQ Technologies Stock Up Today?

Shares of BTQ Technologies Corp. (NASDAQ:BTQ) are rising Thursday after the company announced that it reached a significant technological milestone.

Regeneron's Gene Therapy Shows Significant Gains In Genetic Hearing Loss

Regeneron gene therapy for OTOF-related hearing loss shows rapid, sustained improvements, including normal hearing in some participants.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

News organizations, including Hegseth's former employer Fox, reject new Pentagon reporting rules

Fox News, the former employer of Defense Secretary Pete Hegseth, has joined a near-unanimous outpouring of news organizations rejecting new rules for journalists based in the Pentagon.

What's Going On With Archer Aviation Stock Wednesday?

Shares of Archer Aviation Inc. (NASDAQ: ACHR) are rising Wednesday after the air mobility company confirmed it won a bid for a portfolio of patents.

Oct 23: The Day Elon Changes Everything - Ad

Mark your calendar: October 23, 2025. That's the date I believe Elon Musk could finally unveil his Optimus robot - the same project he says will be "the biggest product ever of any kind." If Elon is right, this could be a $30 trillion tipping point...And regular investors have a rare window to move before the switch flips.

Apple iPhone 17 Pro, Pro Max Ship Times Stay Stable Globally: Analyst

Apple's iPhone 17 Pro and Pro Max maintain stable lead times globally, while the iPhone Air is widely available. Analyst maintains Buy rating with $270 price target.

Trump administration puts on hold $18 billion in funding for New York City infrastructure projects

WASHINGTON (AP) — President Donald Trump's administration said Wednesday it was putting a hold on roughly $18 billion to fund beneath the Hudson River between New York City and New Jersey and the city's expanded project because of .

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

California lawsuit says makers of plastic bags lied about products being recyclable

SACRAMENTO, Calif. (AP) — California ramped up its efforts to curb plastic pollution Friday — suing three plastic-bag makers, alleging the companies falsely claimed their products were recyclable.

This Company Could Challenge NVIDIA's Reign - Ad

This new chip can run at the speed of light and it's changing the game. "TF3" could replace silicon entirely and one American company is producing it commercially. Clients already include NASA and top medical research institutions. It's still under the radar - and that's the opportunity.

Eli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs

Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 diabetes.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service